NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 16 04:00PM ET
394.21
Dollar change
+2.01
Percentage change
0.51
%
IndexS&P 500 P/E53.20 EPS (ttm)7.41 Insider Own6.41% Shs Outstand382.10M Perf Week3.49%
Market Cap150.65B Forward P/E26.57 EPS next Y14.84 Insider Trans-1.63% Shs Float357.68M Perf Month13.71%
Income2.86B PEG4.89 EPS next Q3.07 Inst Own80.53% Short Float1.60% Perf Quarter2.34%
Sales23.22B P/S6.49 EPS this Y9.52% Inst Trans-0.01% Short Ratio3.46 Perf Half Y1.83%
Book/sh54.78 P/B7.20 EPS next Y11.15% ROA6.69% Short Interest5.73M Perf Year21.56%
Cash/sh6.30 P/C62.54 EPS next 5Y10.87% ROE14.26% 52W Range314.93 - 406.19 Perf YTD9.49%
Dividend Est.3.21 (0.81%) P/FCF42.12 EPS past 5Y7.20% ROI8.00% 52W High-2.95% Beta0.93
Dividend TTM3.28 (0.83%) Quick Ratio1.00 Sales past 5Y8.96% Gross Margin61.73% 52W Low25.17% ATR (14)8.91
Dividend Ex-DateJun 30, 2025 Current Ratio1.64 EPS Y/Y TTM-15.22% Oper. Margin22.19% RSI (14)67.79 Volatility1.39% 2.10%
Employees53000 Debt/Eq0.83 Sales Y/Y TTM10.76% Profit Margin12.31% Recom1.72 Target Price430.54
Option/ShortYes / Yes LT Debt/Eq0.71 EPS Q/Q-17.28% Payout41.74% Rel Volume0.67 Prev Close392.20
Sales Surprise3.07% EPS Surprise4.63% Sales Q/Q11.88% EarningsMay 01 AMC Avg Volume1.66M Price394.21
SMA205.28% SMA507.15% SMA2006.99% Trades Volume1,110,515 Change0.51%
Date Action Analyst Rating Change Price Target Change
Feb-26-25Resumed Citigroup Buy $450
Dec-02-24Upgrade Morgan Stanley Equal-Weight → Overweight $370 → $445
Sep-10-24Initiated Wolfe Research Outperform $405
May-30-24Initiated Goldman Neutral $372
May-22-24Upgrade Needham Hold → Buy $392
Jan-31-24Upgrade Canaccord Genuity Hold → Buy $315 → $360
Oct-20-23Initiated ROTH MKM Buy $345
Sep-05-23Upgrade BofA Securities Neutral → Buy $310 → $315
Mar-29-23Initiated UBS Neutral $287
Jan-25-23Initiated KeyBanc Capital Markets Sector Weight
May-14-25 05:42AM
May-10-25 04:10AM
May-09-25 07:47AM
May-08-25 08:00AM
May-07-25 04:55AM
12:40AM Loading…
May-05-25 12:40AM
May-02-25 06:30PM
01:22PM
08:14AM
07:18AM
03:19AM
03:16AM
May-01-25 08:28PM
05:20PM
04:20PM
04:05PM Loading…
04:05PM
08:00AM
Apr-30-25 11:27PM
10:54AM
09:01AM
Apr-29-25 11:40AM
09:11AM
08:00AM
Apr-28-25 09:15AM
Apr-27-25 02:55PM
02:22PM
Apr-26-25 01:53AM
Apr-24-25 10:02AM
Apr-21-25 03:21PM
Apr-17-25 08:10AM
12:21PM Loading…
Apr-15-25 12:21PM
06:46AM
Apr-14-25 05:15PM
Apr-10-25 11:40AM
Apr-09-25 12:19PM
06:27AM
05:05AM
Apr-07-25 10:08AM
08:00AM
Apr-03-25 02:24PM
10:29AM
Apr-01-25 04:26PM
04:05PM
Mar-31-25 03:03PM
11:28AM
04:39AM
Mar-29-25 04:05PM
Mar-26-25 08:29PM
10:15AM
Mar-25-25 04:15PM
Mar-22-25 12:31AM
Mar-20-25 09:40AM
09:05AM
08:23AM
Mar-19-25 11:03AM
Mar-17-25 07:01AM
Mar-12-25 09:00AM
Mar-11-25 03:59PM
08:03AM
Mar-10-25 12:08PM
Mar-06-25 01:36PM
Mar-05-25 09:45AM
Mar-04-25 08:07AM
Mar-03-25 08:07AM
Mar-01-25 06:14PM
Feb-28-25 04:04AM
Feb-26-25 11:18AM
Feb-25-25 06:38AM
Feb-24-25 05:23AM
Feb-20-25 04:49AM
Feb-19-25 08:30AM
Feb-17-25 11:21AM
03:07AM
Feb-16-25 07:07PM
Feb-13-25 05:54PM
08:00AM
Feb-12-25 09:14AM
06:55AM
Feb-10-25 04:05PM
04:04AM
Feb-07-25 05:06AM
Feb-05-25 08:00AM
Jan-31-25 04:34PM
03:07PM
02:10AM
Jan-29-25 01:48PM
10:31AM
08:19AM
06:44AM
Jan-28-25 06:00PM
05:15PM
05:11PM
04:35PM
04:29PM
04:05PM
04:05PM
04:05PM
Jan-26-25 01:22PM
Jan-23-25 09:15AM
Jan-17-25 04:20PM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Berry William E JrVP, Chief Accounting OfficerMay 12 '25Sale388.561,241482,2022,833May 14 04:05 PM
William Berry JrOfficerMay 12 '25Proposed Sale388.561,241482,197May 12 04:18 PM
Allan GolstonDirectorMay 12 '25Proposed Sale390.066,1012,379,738May 12 11:10 AM
Allan GolstonDirectorMay 09 '25Proposed Sale383.674,1841,605,264May 09 11:49 AM
STRYKER RONDA EDirectorMay 06 '25Sale376.96200,00075,391,8483,417,326May 08 04:58 PM
Glenn BoehnleinOfficerMay 07 '25Proposed Sale383.099,0003,447,803May 07 04:03 PM
Stiles Spencer SGroup PresidentMar 21 '25Option Exercise0.00314068,603Mar 25 04:45 PM
Pierce James AndrewGroup PresidentMar 21 '25Option Exercise0.00314072,561Mar 25 04:41 PM
Menon VijuGroup PresidentMar 21 '25Option Exercise0.00187016,934Mar 25 04:37 PM
Lobo KevinChair and CEOMar 21 '25Option Exercise0.001,0850145,625Mar 25 04:32 PM
Fletcher Robert SVP, Chief Legal OfficerMar 21 '25Option Exercise0.00144015,261Mar 25 04:28 PM
Fink M KathrynVP, Chief HR OfficerMar 21 '25Option Exercise0.00102014,157Mar 25 04:24 PM
Boehnlein Glenn SVP, Chief Financial OfficerMar 21 '25Option Exercise0.00314018,358Mar 25 04:20 PM
Becker Yin CVP, Chief Corp Affairs OfficerMar 21 '25Option Exercise0.0042034,586Mar 25 04:11 PM
Becker Yin CVP, Chief Corp Affairs OfficerFeb 27 '25Option Exercise96.644,980481,26735,729Feb 27 06:15 PM
Golston Allan C.DirectorFeb 18 '25Option Exercise122.513,605441,64918,500Feb 19 08:46 PM
Golston Allan C.DirectorFeb 18 '25Sale383.072,458941,58614,895Feb 19 08:46 PM
Allan GolstonDirectorFeb 18 '25Proposed Sale382.832,458941,000Feb 18 03:15 PM
Silvernail Andrew KDirectorFeb 03 '25Option Exercise93.063,795353,16314,705Feb 04 04:27 PM
STRYKER RONDA EDirectorJan 30 '25Option Exercise93.063,795353,1637,735Feb 03 04:44 PM
STRYKER RONDA EDirectorJan 31 '25Sale392.24201,39278,993,0683,642,075Feb 03 04:44 PM
STRYKER RONDA EDirectorJan 31 '25Proposed Sale389.92236,00092,020,000Feb 03 08:58 AM
Stiles Spencer SGroup PresidentJan 29 '25Option Exercise93.0610,210950,14360,821Jan 30 04:45 PM
Pierce James AndrewGroup PresidentJan 29 '25Option Exercise93.069,455879,88264,868Jan 30 04:38 PM
Boehnlein Glenn SVP, Chief Financial OfficerDec 31 '24Option Exercise122.5130036,7535,331Jan 02 04:44 PM
Boehnlein Glenn SVP, Chief Financial OfficerDec 27 '24Option Exercise122.512,000245,0206,373Dec 30 04:19 PM
Boehnlein Glenn SVP, Chief Financial OfficerNov 18 '24Option Exercise122.514,500551,2957,352Nov 19 04:36 PM
Stiles Spencer SGroup PresidentNov 15 '24Sale391.16514201,05650,611Nov 18 04:58 PM
Stiles Spencer SOfficerNov 15 '24Proposed Sale389.88514200,398Nov 15 11:39 AM
Lobo KevinChair and CEONov 07 '24Option Exercise93.06156,89014,600,183256,917Nov 08 04:20 PM
Lobo KevinChair and CEONov 07 '24Sale368.7057,31321,131,479100,027Nov 08 04:20 PM
Kevin LoboOfficerNov 07 '24Proposed Sale368.1557,31321,100,000Nov 07 04:43 PM
STRYKER RONDA EDirectorNov 05 '24Sale367.37230,00084,494,9903,086,608Nov 07 04:33 PM
Becker Yin CVP, Chief Corp Affairs OfficerNov 05 '24Option Exercise96.644,980481,26733,938Nov 05 06:13 PM
STRYKER RONDA EDirectorNov 05 '24Proposed Sale365.00230,00083,950,000Nov 05 10:10 AM
Fink M KathrynVP, Chief HR OfficerSep 16 '24Option Exercise122.517,347900,08117,389Sep 17 06:01 PM
Fink M KathrynVP, Chief HR OfficerSep 17 '24Sale366.987,3472,696,18610,042Sep 17 06:01 PM
Fink M KathrynVP, Chief HR OfficerSep 13 '24Sale370.002,121784,77010,042Sep 17 06:01 PM
Fink M KathrynOfficerSep 17 '24Proposed Sale371.197,3472,727,133Sep 17 04:07 PM
Fink M KathrynOfficerSep 13 '24Proposed Sale370.002,121784,770Sep 13 04:06 PM
Menon VijuGroup PresidentAug 27 '24Sale355.00600213,0009,069Aug 27 05:22 PM
Viju MenonOfficerAug 27 '24Proposed Sale355.00600213,000Aug 27 04:04 PM
STRYKER RONDA EDirectorAug 06 '24Sale323.46190,00061,457,1493,316,608Aug 08 04:23 PM
STRYKER RONDA EDirectorAug 06 '24Proposed Sale322.45190,00061,265,500Aug 06 10:57 AM
Boehnlein Glenn SVP, Chief Financial OfficerAug 02 '24Sale333.0020,0006,660,0002,852Aug 02 04:17 PM
Glenn BoehnleinOfficerAug 02 '24Proposed Sale333.0020,0006,659,994Aug 02 11:43 AM
Boehnlein Glenn SVP, Chief Financial OfficerJul 02 '24Option Exercise122.5125,0003,062,75040,012Jul 03 04:33 PM
Fletcher Robert SVP, Chief Legal OfficerMay 22 '24Sale332.992,007668,3088,896May 23 04:06 PM